IL300978A - Methods and systems for predicting response to anti-TNF treatments - Google Patents
Methods and systems for predicting response to anti-TNF treatmentsInfo
- Publication number
- IL300978A IL300978A IL300978A IL30097823A IL300978A IL 300978 A IL300978 A IL 300978A IL 300978 A IL300978 A IL 300978A IL 30097823 A IL30097823 A IL 30097823A IL 300978 A IL300978 A IL 300978A
- Authority
- IL
- Israel
- Prior art keywords
- gene expression
- tnf therapy
- genes
- subjects
- responsive
- Prior art date
Links
- 230000004044 response Effects 0.000 title claims description 312
- 238000002560 therapeutic procedure Methods 0.000 title claims description 285
- 238000000034 method Methods 0.000 title claims description 170
- 230000014509 gene expression Effects 0.000 claims description 345
- 108090000623 proteins and genes Proteins 0.000 claims description 280
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 188
- 201000010099 disease Diseases 0.000 claims description 109
- 208000035475 disorder Diseases 0.000 claims description 78
- 229960000598 infliximab Drugs 0.000 claims description 60
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 51
- 201000006704 Ulcerative Colitis Diseases 0.000 claims description 49
- 230000015654 memory Effects 0.000 claims description 38
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 34
- 230000004043 responsiveness Effects 0.000 claims description 32
- 238000004458 analytical method Methods 0.000 claims description 27
- 101000832685 Homo sapiens Small ubiquitin-related modifier 2 Proteins 0.000 claims description 22
- 102100024542 Small ubiquitin-related modifier 2 Human genes 0.000 claims description 22
- 208000011231 Crohn disease Diseases 0.000 claims description 21
- 229960002964 adalimumab Drugs 0.000 claims description 20
- 239000012472 biological sample Substances 0.000 claims description 19
- 108010008165 Etanercept Proteins 0.000 claims description 18
- 238000012549 training Methods 0.000 claims description 18
- 201000004681 Psoriasis Diseases 0.000 claims description 17
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 16
- 208000023275 Autoimmune disease Diseases 0.000 claims description 13
- 229960000106 biosimilars Drugs 0.000 claims description 13
- 238000003559 RNA-seq method Methods 0.000 claims description 12
- 229960000403 etanercept Drugs 0.000 claims description 12
- 238000002965 ELISA Methods 0.000 claims description 10
- 201000001263 Psoriatic Arthritis Diseases 0.000 claims description 10
- 208000036824 Psoriatic arthropathy Diseases 0.000 claims description 10
- 230000001684 chronic effect Effects 0.000 claims description 10
- 238000002493 microarray Methods 0.000 claims description 10
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims description 9
- 206010060742 Endocrine ophthalmopathy Diseases 0.000 claims description 9
- 208000003084 Graves Ophthalmopathy Diseases 0.000 claims description 9
- 208000003456 Juvenile Arthritis Diseases 0.000 claims description 9
- 206010059176 Juvenile idiopathic arthritis Diseases 0.000 claims description 9
- 206010046851 Uveitis Diseases 0.000 claims description 9
- 206010047642 Vitiligo Diseases 0.000 claims description 9
- 208000006673 asthma Diseases 0.000 claims description 9
- 239000011324 bead Substances 0.000 claims description 9
- 208000002557 hidradenitis Diseases 0.000 claims description 9
- 201000007162 hidradenitis suppurativa Diseases 0.000 claims description 9
- 201000002215 juvenile rheumatoid arthritis Diseases 0.000 claims description 9
- 201000006417 multiple sclerosis Diseases 0.000 claims description 9
- 102100028289 Coatomer subunit delta Human genes 0.000 claims description 7
- 101000860881 Homo sapiens Coatomer subunit delta Proteins 0.000 claims description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 238000003753 real-time PCR Methods 0.000 claims description 6
- 101000753769 Homo sapiens Thiamine-triphosphatase Proteins 0.000 claims description 5
- 102100021911 Thiamine-triphosphatase Human genes 0.000 claims description 5
- QYAPHLRPFNSDNH-MRFRVZCGSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O QYAPHLRPFNSDNH-MRFRVZCGSA-N 0.000 claims description 4
- 102100026127 Clathrin heavy chain 1 Human genes 0.000 claims description 4
- 102100030445 Histone H4 transcription factor Human genes 0.000 claims description 4
- 101000912851 Homo sapiens Clathrin heavy chain 1 Proteins 0.000 claims description 4
- 101000842273 Homo sapiens Histone H4 transcription factor Proteins 0.000 claims description 4
- 102000051628 Interleukin-1 receptor antagonist Human genes 0.000 claims description 4
- 108700021006 Interleukin-1 receptor antagonist Proteins 0.000 claims description 4
- VHOGYURTWQBHIL-UHFFFAOYSA-N leflunomide Chemical compound O1N=CC(C(=O)NC=2C=CC(=CC=2)C(F)(F)F)=C1C VHOGYURTWQBHIL-UHFFFAOYSA-N 0.000 claims description 4
- 229960004641 rituximab Drugs 0.000 claims description 4
- SYIKUFDOYJFGBQ-YLAFAASESA-N tofacitinib citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)C1=NC=NC2=C1C=CN2 SYIKUFDOYJFGBQ-YLAFAASESA-N 0.000 claims description 4
- HMLGSIZOMSVISS-ONJSNURVSA-N (7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound N([C@@H]1C(N2C(=C(C=C)CSC21)C(O)=O)=O)C(=O)\C(=N/OCOC(=O)C(C)(C)C)C1=CSC(N)=N1 HMLGSIZOMSVISS-ONJSNURVSA-N 0.000 claims description 3
- 102100034001 DNA replication licensing factor MCM5 Human genes 0.000 claims description 3
- 101001017545 Homo sapiens DNA replication licensing factor MCM5 Proteins 0.000 claims description 3
- 229960003697 abatacept Drugs 0.000 claims description 3
- 229960004238 anakinra Drugs 0.000 claims description 3
- 229950006348 sarilumab Drugs 0.000 claims description 3
- 229960003989 tocilizumab Drugs 0.000 claims description 3
- 229960004247 tofacitinib citrate Drugs 0.000 claims description 3
- 229960004914 vedolizumab Drugs 0.000 claims description 3
- 102100036409 Activated CDC42 kinase 1 Human genes 0.000 claims description 2
- 102100030907 Aryl hydrocarbon receptor nuclear translocator Human genes 0.000 claims description 2
- 101000690445 Caenorhabditis elegans Aryl hydrocarbon receptor nuclear translocator homolog Proteins 0.000 claims description 2
- 108050002772 E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 claims description 2
- 102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 claims description 2
- 102100020760 Ferritin heavy chain Human genes 0.000 claims description 2
- 101000928956 Homo sapiens Activated CDC42 kinase 1 Proteins 0.000 claims description 2
- 101000793115 Homo sapiens Aryl hydrocarbon receptor nuclear translocator Proteins 0.000 claims description 2
- 101001002987 Homo sapiens Ferritin heavy chain Proteins 0.000 claims description 2
- 101001055354 Homo sapiens Mediator of RNA polymerase II transcription subunit 6 Proteins 0.000 claims description 2
- 101000628796 Homo sapiens Microsomal glutathione S-transferase 2 Proteins 0.000 claims description 2
- 101000702560 Homo sapiens Probable global transcription activator SNF2L1 Proteins 0.000 claims description 2
- 101000683518 Homo sapiens RRP15-like protein Proteins 0.000 claims description 2
- 101001094146 Homo sapiens SUMO-activating enzyme subunit 2 Proteins 0.000 claims description 2
- 102100026174 Mediator of RNA polymerase II transcription subunit 6 Human genes 0.000 claims description 2
- 102100026723 Microsomal glutathione S-transferase 2 Human genes 0.000 claims description 2
- 108010018525 NFATC Transcription Factors Proteins 0.000 claims description 2
- 102000002673 NFATC Transcription Factors Human genes 0.000 claims description 2
- 102100031031 Probable global transcription activator SNF2L1 Human genes 0.000 claims description 2
- 102100023534 RRP15-like protein Human genes 0.000 claims description 2
- 102100035250 SUMO-activating enzyme subunit 2 Human genes 0.000 claims description 2
- 238000003762 quantitative reverse transcription PCR Methods 0.000 claims 2
- 101100129500 Caenorhabditis elegans max-2 gene Proteins 0.000 claims 1
- 102100034628 Cilia- and flagella-associated protein 206 Human genes 0.000 claims 1
- 101000710053 Homo sapiens Cilia- and flagella-associated protein 206 Proteins 0.000 claims 1
- 101001137337 Homo sapiens Transcriptional activator protein Pur-alpha Proteins 0.000 claims 1
- 102100035715 Transcriptional activator protein Pur-alpha Human genes 0.000 claims 1
- 241000282414 Homo sapiens Species 0.000 description 74
- 238000011282 treatment Methods 0.000 description 47
- 238000005516 engineering process Methods 0.000 description 35
- 230000003993 interaction Effects 0.000 description 34
- 238000010200 validation analysis Methods 0.000 description 32
- 239000000523 sample Substances 0.000 description 31
- 102100040247 Tumor necrosis factor Human genes 0.000 description 30
- 239000003795 chemical substances by application Substances 0.000 description 28
- 150000001413 amino acids Chemical class 0.000 description 25
- 102000004169 proteins and genes Human genes 0.000 description 24
- 102000004196 processed proteins & peptides Human genes 0.000 description 22
- 108090000765 processed proteins & peptides Proteins 0.000 description 22
- 238000012360 testing method Methods 0.000 description 22
- 229920001184 polypeptide Polymers 0.000 description 21
- 239000003814 drug Substances 0.000 description 20
- 238000013528 artificial neural network Methods 0.000 description 18
- 238000004891 communication Methods 0.000 description 17
- 230000006854 communication Effects 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 230000008569 process Effects 0.000 description 16
- 238000013459 approach Methods 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 13
- 238000003556 assay Methods 0.000 description 13
- 238000001574 biopsy Methods 0.000 description 13
- 229940124597 therapeutic agent Drugs 0.000 description 13
- 239000000126 substance Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 230000008859 change Effects 0.000 description 11
- 238000002790 cross-validation Methods 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 238000013507 mapping Methods 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- 239000002451 tumor necrosis factor inhibitor Substances 0.000 description 11
- 239000000090 biomarker Substances 0.000 description 10
- 230000001413 cellular effect Effects 0.000 description 10
- 238000001514 detection method Methods 0.000 description 10
- 230000000875 corresponding effect Effects 0.000 description 9
- 239000005557 antagonist Substances 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 230000002596 correlated effect Effects 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 230000002068 genetic effect Effects 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- 230000010399 physical interaction Effects 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 229940048921 humira Drugs 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 238000012423 maintenance Methods 0.000 description 7
- 150000007523 nucleic acids Chemical class 0.000 description 7
- 229940116176 remicade Drugs 0.000 description 7
- 238000011285 therapeutic regimen Methods 0.000 description 7
- 229940046728 tumor necrosis factor alpha inhibitor Drugs 0.000 description 7
- 238000002052 colonoscopy Methods 0.000 description 6
- 238000004590 computer program Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 230000000977 initiatory effect Effects 0.000 description 6
- 108020004707 nucleic acids Proteins 0.000 description 6
- 102000039446 nucleic acids Human genes 0.000 description 6
- 230000037361 pathway Effects 0.000 description 6
- 230000004850 protein–protein interaction Effects 0.000 description 6
- 239000013558 reference substance Substances 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 230000011664 signaling Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000003442 weekly effect Effects 0.000 description 6
- 108700039887 Essential Genes Proteins 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 238000004422 calculation algorithm Methods 0.000 description 5
- 238000002648 combination therapy Methods 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 238000010195 expression analysis Methods 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 230000002503 metabolic effect Effects 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 102100028909 Heterogeneous nuclear ribonucleoprotein K Human genes 0.000 description 4
- 101000838964 Homo sapiens Heterogeneous nuclear ribonucleoprotein K Proteins 0.000 description 4
- 230000006978 adaptation Effects 0.000 description 4
- 229960003115 certolizumab pegol Drugs 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 229940073621 enbrel Drugs 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000002962 histologic effect Effects 0.000 description 4
- 238000001990 intravenous administration Methods 0.000 description 4
- 238000010801 machine learning Methods 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 238000010208 microarray analysis Methods 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000002331 protein detection Methods 0.000 description 4
- 230000006916 protein interaction Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 238000010254 subcutaneous injection Methods 0.000 description 4
- 239000007929 subcutaneous injection Substances 0.000 description 4
- 102100030686 Beta-sarcoglycan Human genes 0.000 description 3
- 102100029951 Estrogen receptor beta Human genes 0.000 description 3
- 102100029974 GTPase HRas Human genes 0.000 description 3
- 108091059596 H3F3A Proteins 0.000 description 3
- 102100039236 Histone H3.3 Human genes 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 101000703495 Homo sapiens Beta-sarcoglycan Proteins 0.000 description 3
- 101001010910 Homo sapiens Estrogen receptor beta Proteins 0.000 description 3
- 101000584633 Homo sapiens GTPase HRas Proteins 0.000 description 3
- 101000577877 Homo sapiens Stromelysin-3 Proteins 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 3
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 3
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 3
- 108010003723 Single-Domain Antibodies Proteins 0.000 description 3
- 102100034803 Small nuclear ribonucleoprotein-associated protein N Human genes 0.000 description 3
- 102100028847 Stromelysin-3 Human genes 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 230000001363 autoimmune Effects 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000001072 colon Anatomy 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 238000006206 glycosylation reaction Methods 0.000 description 3
- 229960001743 golimumab Drugs 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 208000002551 irritable bowel syndrome Diseases 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229960000485 methotrexate Drugs 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 229940068638 simponi Drugs 0.000 description 3
- 108010039827 snRNP Core Proteins Proteins 0.000 description 3
- 238000013517 stratification Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 102100025007 14-3-3 protein epsilon Human genes 0.000 description 2
- 102100038074 5'-AMP-activated protein kinase subunit beta-1 Human genes 0.000 description 2
- 101150106774 9 gene Proteins 0.000 description 2
- 102000034257 ADP-Ribosylation Factor 6 Human genes 0.000 description 2
- 108090000067 ADP-Ribosylation Factor 6 Proteins 0.000 description 2
- 102100026401 Actin-related protein 2/3 complex subunit 5-like protein Human genes 0.000 description 2
- 102100033894 Ankyrin repeat and SOCS box protein 16 Human genes 0.000 description 2
- 102100040269 Cleavage stimulation factor subunit 2 Human genes 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102100039077 Cytosolic 10-formyltetrahydrofolate dehydrogenase Human genes 0.000 description 2
- 206010061818 Disease progression Diseases 0.000 description 2
- 102100028067 EGF-containing fibulin-like extracellular matrix protein 2 Human genes 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 102100034523 Histone H4 Human genes 0.000 description 2
- 101000760079 Homo sapiens 14-3-3 protein epsilon Proteins 0.000 description 2
- 101000742701 Homo sapiens 5'-AMP-activated protein kinase subunit beta-1 Proteins 0.000 description 2
- 101000785745 Homo sapiens Actin-related protein 2/3 complex subunit 5-like protein Proteins 0.000 description 2
- 101000925518 Homo sapiens Ankyrin repeat and SOCS box protein 16 Proteins 0.000 description 2
- 101000891793 Homo sapiens Cleavage stimulation factor subunit 2 Proteins 0.000 description 2
- 101000959030 Homo sapiens Cytosolic 10-formyltetrahydrofolate dehydrogenase Proteins 0.000 description 2
- 101001060248 Homo sapiens EGF-containing fibulin-like extracellular matrix protein 2 Proteins 0.000 description 2
- 101001067880 Homo sapiens Histone H4 Proteins 0.000 description 2
- 101001039170 Homo sapiens Leucine-rich repeat-containing protein 23 Proteins 0.000 description 2
- 101001081220 Homo sapiens RanBP-type and C3HC4-type zinc finger-containing protein 1 Proteins 0.000 description 2
- 101000633429 Homo sapiens Structural maintenance of chromosomes protein 1A Proteins 0.000 description 2
- 101000655421 Homo sapiens Tuftelin-interacting protein 11 Proteins 0.000 description 2
- 101000807337 Homo sapiens Ubiquitin-conjugating enzyme E2 B Proteins 0.000 description 2
- 101000608584 Homo sapiens Ubiquitin-like modifier-activating enzyme 5 Proteins 0.000 description 2
- 101000667209 Homo sapiens Vacuolar protein sorting-associated protein 72 homolog Proteins 0.000 description 2
- 206010062016 Immunosuppression Diseases 0.000 description 2
- 150000008575 L-amino acids Chemical class 0.000 description 2
- 238000007397 LAMP assay Methods 0.000 description 2
- 102100040691 Leucine-rich repeat-containing protein 23 Human genes 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 102100027716 RanBP-type and C3HC4-type zinc finger-containing protein 1 Human genes 0.000 description 2
- 108091006632 SLC13A3 Proteins 0.000 description 2
- 102000008935 SMN Complex Proteins Human genes 0.000 description 2
- 108010049037 SMN Complex Proteins Proteins 0.000 description 2
- 102100035208 Solute carrier family 13 member 3 Human genes 0.000 description 2
- 102100029538 Structural maintenance of chromosomes protein 1A Human genes 0.000 description 2
- 102100032856 Tuftelin-interacting protein 11 Human genes 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102100037262 Ubiquitin-conjugating enzyme E2 B Human genes 0.000 description 2
- 102100039197 Ubiquitin-like modifier-activating enzyme 5 Human genes 0.000 description 2
- 102100039098 Vacuolar protein sorting-associated protein 72 homolog Human genes 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- 230000004186 co-expression Effects 0.000 description 2
- 230000000112 colonic effect Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000003246 corticosteroid Substances 0.000 description 2
- 229960001334 corticosteroids Drugs 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 230000005750 disease progression Effects 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 238000003364 immunohistochemistry Methods 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000011221 initial treatment Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 206010025135 lupus erythematosus Diseases 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000002626 targeted therapy Methods 0.000 description 2
- 230000004797 therapeutic response Effects 0.000 description 2
- 102100034538 28S ribosomal protein S12, mitochondrial Human genes 0.000 description 1
- MXCVHSXCXPHOLP-UHFFFAOYSA-N 4-oxo-6-propylchromene-2-carboxylic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=CC(CCC)=CC=C21 MXCVHSXCXPHOLP-UHFFFAOYSA-N 0.000 description 1
- 102100021548 5-methylcytosine rRNA methyltransferase NSUN4 Human genes 0.000 description 1
- 102100028324 ADP-ribose glycohydrolase MACROD1 Human genes 0.000 description 1
- 102100025753 AP2-interacting clathrin-endocytosis protein Human genes 0.000 description 1
- 102100029005 ATP-dependent RNA helicase SUPV3L1, mitochondrial Human genes 0.000 description 1
- 102100032814 ATP-dependent zinc metalloprotease YME1L1 Human genes 0.000 description 1
- 102100028249 Acetyl-coenzyme A transporter 1 Human genes 0.000 description 1
- 102100030963 Activating transcription factor 7-interacting protein 1 Human genes 0.000 description 1
- 102100032158 Adenylate cyclase type 6 Human genes 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 102100035028 Alpha-L-iduronidase Human genes 0.000 description 1
- 102100029233 Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase Human genes 0.000 description 1
- 102100036440 Amyloid-beta A4 precursor protein-binding family A member 3 Human genes 0.000 description 1
- 102100036822 Ankyrin repeat and KH domain-containing protein 1 Human genes 0.000 description 1
- 102100040199 Apolipoprotein B receptor Human genes 0.000 description 1
- 102000004391 Aquaporin 6 Human genes 0.000 description 1
- 108090000977 Aquaporin 6 Proteins 0.000 description 1
- 101000686547 Arabidopsis thaliana 30S ribosomal protein S1, chloroplastic Proteins 0.000 description 1
- 102100030356 Arginase-2, mitochondrial Human genes 0.000 description 1
- 102100034224 Armadillo repeat-containing X-linked protein 2 Human genes 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 208000025705 Axial Spondyloarthritis Diseases 0.000 description 1
- 102100022526 Bone morphogenetic protein 5 Human genes 0.000 description 1
- 102000014816 CACNA1D Human genes 0.000 description 1
- 102100030155 CDC42 small effector protein 2 Human genes 0.000 description 1
- 102000014572 CHFR Human genes 0.000 description 1
- 102100031973 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 Human genes 0.000 description 1
- 102100025172 Calpain-1 catalytic subunit Human genes 0.000 description 1
- 101001110283 Canis lupus familiaris Ras-related C3 botulinum toxin substrate 1 Proteins 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 description 1
- 208000006029 Cardiomegaly Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102100035904 Caspase-1 Human genes 0.000 description 1
- 102100028918 Catenin alpha-3 Human genes 0.000 description 1
- 102100024940 Cathepsin K Human genes 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 102100032375 Coiled-coil domain-containing protein 105 Human genes 0.000 description 1
- 102100023774 Cold-inducible RNA-binding protein Human genes 0.000 description 1
- 102100033601 Collagen alpha-1(I) chain Human genes 0.000 description 1
- 102100031576 Collagen alpha-1(XXV) chain Human genes 0.000 description 1
- 102100031502 Collagen alpha-2(V) chain Human genes 0.000 description 1
- 102100030977 Collagen alpha-3(IX) chain Human genes 0.000 description 1
- 102100025890 Complement C1q tumor necrosis factor-related protein 3 Human genes 0.000 description 1
- 208000014997 Crohn colitis Diseases 0.000 description 1
- 102100022052 Cyclin N-terminal domain-containing protein 1 Human genes 0.000 description 1
- 102100031685 Cyclin-dependent kinase-like 2 Human genes 0.000 description 1
- 102100038387 Cystatin-SN Human genes 0.000 description 1
- 102100031621 Cysteine and glycine-rich protein 2 Human genes 0.000 description 1
- 108010026925 Cytochrome P-450 CYP2C19 Proteins 0.000 description 1
- 102100029363 Cytochrome P450 2C19 Human genes 0.000 description 1
- 102100022027 Cytochrome P450 4X1 Human genes 0.000 description 1
- 150000008574 D-amino acids Chemical class 0.000 description 1
- 102100029586 DDB1- and CUL4-associated factor 16 Human genes 0.000 description 1
- 102000012677 DET1 Human genes 0.000 description 1
- 101150113651 DET1 gene Proteins 0.000 description 1
- 102100021147 DNA mismatch repair protein Msh6 Human genes 0.000 description 1
- 208000016192 Demyelinating disease Diseases 0.000 description 1
- 102100022730 Diacylglycerol kinase gamma Human genes 0.000 description 1
- 102100032302 Diphosphoinositol polyphosphate phosphohydrolase NUDT4B Human genes 0.000 description 1
- 102100037927 DnaJ homolog subfamily B member 11 Human genes 0.000 description 1
- 102100033208 Dysbindin domain-containing protein 1 Human genes 0.000 description 1
- 102100037359 EF-hand calcium-binding domain-containing protein 13 Human genes 0.000 description 1
- 102100023733 Ephrin-B3 Human genes 0.000 description 1
- 108010044085 Ephrin-B3 Proteins 0.000 description 1
- 102100022457 Eukaryotic translation initiation factor 4E-binding protein 3 Human genes 0.000 description 1
- 102100024516 F-box only protein 5 Human genes 0.000 description 1
- 102000009109 Fc receptors Human genes 0.000 description 1
- 108010087819 Fc receptors Proteins 0.000 description 1
- 108010008177 Fd immunoglobulins Proteins 0.000 description 1
- 102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 description 1
- 101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 description 1
- 102100031812 Fibulin-1 Human genes 0.000 description 1
- 102100036552 GATOR complex protein WDR24 Human genes 0.000 description 1
- 102100036715 GPALPP motifs-containing protein 1 Human genes 0.000 description 1
- 102100033414 Gamma-tubulin complex component 6 Human genes 0.000 description 1
- 102100038308 General transcription factor IIH subunit 1 Human genes 0.000 description 1
- 102100033366 Glutathione hydrolase 1 proenzyme Human genes 0.000 description 1
- 102100033322 Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 Human genes 0.000 description 1
- 102100039321 HAUS augmin-like complex subunit 7 Human genes 0.000 description 1
- 102100039389 Hepatoma-derived growth factor-related protein 3 Human genes 0.000 description 1
- 102100037848 Heterochromatin protein 1-binding protein 3 Human genes 0.000 description 1
- 102100029009 High mobility group protein HMG-I/HMG-Y Human genes 0.000 description 1
- 102100034535 Histone H3.1 Human genes 0.000 description 1
- 102100021454 Histone deacetylase 4 Human genes 0.000 description 1
- 102100025061 Homeobox protein Hox-B7 Human genes 0.000 description 1
- 102100022599 Homeobox protein Hox-C6 Human genes 0.000 description 1
- 101000639726 Homo sapiens 28S ribosomal protein S12, mitochondrial Proteins 0.000 description 1
- 101001108645 Homo sapiens 5-methylcytosine rRNA methyltransferase NSUN4 Proteins 0.000 description 1
- 101000578912 Homo sapiens ADP-ribose glycohydrolase MACROD1 Proteins 0.000 description 1
- 101000696694 Homo sapiens ATP-dependent RNA helicase SUPV3L1, mitochondrial Proteins 0.000 description 1
- 101000583854 Homo sapiens Activating transcription factor 7-interacting protein 1 Proteins 0.000 description 1
- 101000775489 Homo sapiens Adenylate cyclase type 6 Proteins 0.000 description 1
- 101001019502 Homo sapiens Alpha-L-iduronidase Proteins 0.000 description 1
- 101000634075 Homo sapiens Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase Proteins 0.000 description 1
- 101000928673 Homo sapiens Amyloid-beta A4 precursor protein-binding family A member 3 Proteins 0.000 description 1
- 101000928335 Homo sapiens Ankyrin repeat and KH domain-containing protein 1 Proteins 0.000 description 1
- 101000889959 Homo sapiens Apolipoprotein B receptor Proteins 0.000 description 1
- 101000792835 Homo sapiens Arginase-2, mitochondrial Proteins 0.000 description 1
- 101000925939 Homo sapiens Armadillo repeat-containing X-linked protein 2 Proteins 0.000 description 1
- 101000761857 Homo sapiens BTB/POZ domain-containing protein 8 Proteins 0.000 description 1
- 101000899388 Homo sapiens Bone morphogenetic protein 5 Proteins 0.000 description 1
- 101000794294 Homo sapiens CDC42 small effector protein 2 Proteins 0.000 description 1
- 101000703758 Homo sapiens CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 Proteins 0.000 description 1
- 101000934069 Homo sapiens Calpain-1 catalytic subunit Proteins 0.000 description 1
- 101000715398 Homo sapiens Caspase-1 Proteins 0.000 description 1
- 101000916179 Homo sapiens Catenin alpha-3 Proteins 0.000 description 1
- 101000761509 Homo sapiens Cathepsin K Proteins 0.000 description 1
- 101000740970 Homo sapiens Cathepsin O Proteins 0.000 description 1
- 101000868795 Homo sapiens Coiled-coil domain-containing protein 105 Proteins 0.000 description 1
- 101000906744 Homo sapiens Cold-inducible RNA-binding protein Proteins 0.000 description 1
- 101000940250 Homo sapiens Collagen alpha-1(XXV) chain Proteins 0.000 description 1
- 101000941594 Homo sapiens Collagen alpha-2(V) chain Proteins 0.000 description 1
- 101000919644 Homo sapiens Collagen alpha-3(IX) chain Proteins 0.000 description 1
- 101000933673 Homo sapiens Complement C1q tumor necrosis factor-related protein 3 Proteins 0.000 description 1
- 101000900815 Homo sapiens Cyclin N-terminal domain-containing protein 1 Proteins 0.000 description 1
- 101000777764 Homo sapiens Cyclin-dependent kinase-like 2 Proteins 0.000 description 1
- 101000884768 Homo sapiens Cystatin-SN Proteins 0.000 description 1
- 101000940752 Homo sapiens Cysteine and glycine-rich protein 2 Proteins 0.000 description 1
- 101000917435 Homo sapiens DDB1- and CUL4-associated factor 16 Proteins 0.000 description 1
- 101000968658 Homo sapiens DNA mismatch repair protein Msh6 Proteins 0.000 description 1
- 101001044807 Homo sapiens Diacylglycerol kinase gamma Proteins 0.000 description 1
- 101000590225 Homo sapiens Diphosphoinositol polyphosphate phosphohydrolase NUDT4B Proteins 0.000 description 1
- 101000805858 Homo sapiens DnaJ homolog subfamily B member 11 Proteins 0.000 description 1
- 101000871246 Homo sapiens Dysbindin domain-containing protein 1 Proteins 0.000 description 1
- 101000942970 Homo sapiens E3 ubiquitin-protein ligase CHFR Proteins 0.000 description 1
- 101000880228 Homo sapiens EF-hand calcium-binding domain-containing protein 13 Proteins 0.000 description 1
- 101000678288 Homo sapiens Eukaryotic translation initiation factor 4E-binding protein 3 Proteins 0.000 description 1
- 101000824114 Homo sapiens F-box only protein 31 Proteins 0.000 description 1
- 101001052797 Homo sapiens F-box only protein 5 Proteins 0.000 description 1
- 101001065276 Homo sapiens Fibulin-1 Proteins 0.000 description 1
- 101000782155 Homo sapiens GATOR complex protein WDR24 Proteins 0.000 description 1
- 101001072428 Homo sapiens GPALPP motifs-containing protein 1 Proteins 0.000 description 1
- 101000926908 Homo sapiens Gamma-tubulin complex component 6 Proteins 0.000 description 1
- 101000666405 Homo sapiens General transcription factor IIH subunit 1 Proteins 0.000 description 1
- 101000997558 Homo sapiens Glutathione hydrolase 1 proenzyme Proteins 0.000 description 1
- 101000926798 Homo sapiens Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 Proteins 0.000 description 1
- 101001035814 Homo sapiens HAUS augmin-like complex subunit 7 Proteins 0.000 description 1
- 101001025546 Homo sapiens Heterochromatin protein 1-binding protein 3 Proteins 0.000 description 1
- 101000986380 Homo sapiens High mobility group protein HMG-I/HMG-Y Proteins 0.000 description 1
- 101001067844 Homo sapiens Histone H3.1 Proteins 0.000 description 1
- 101000899259 Homo sapiens Histone deacetylase 4 Proteins 0.000 description 1
- 101001077539 Homo sapiens Homeobox protein Hox-B7 Proteins 0.000 description 1
- 101001045154 Homo sapiens Homeobox protein Hox-C6 Proteins 0.000 description 1
- 101000840266 Homo sapiens Immunoglobulin lambda-like polypeptide 5 Proteins 0.000 description 1
- 101000975428 Homo sapiens Inositol 1,4,5-trisphosphate receptor type 1 Proteins 0.000 description 1
- 101001054823 Homo sapiens Inositol polyphosphate 1-phosphatase Proteins 0.000 description 1
- 101000730000 Homo sapiens Late secretory pathway protein AVL9 homolog Proteins 0.000 description 1
- 101001004868 Homo sapiens Leucine-rich repeat-containing protein 27 Proteins 0.000 description 1
- 101001043596 Homo sapiens Low-density lipoprotein receptor-related protein 3 Proteins 0.000 description 1
- 101001090688 Homo sapiens Lymphocyte cytosolic protein 2 Proteins 0.000 description 1
- 101000657049 Homo sapiens Lysine-specific demethylase 9 Proteins 0.000 description 1
- 101001128500 Homo sapiens Marginal zone B- and B1-cell-specific protein Proteins 0.000 description 1
- 101000636210 Homo sapiens Matrix-remodeling-associated protein 7 Proteins 0.000 description 1
- 101001116514 Homo sapiens Myotubularin-related protein 13 Proteins 0.000 description 1
- 101000636581 Homo sapiens N-alpha-acetyltransferase 40 Proteins 0.000 description 1
- 101001076431 Homo sapiens NF-kappa-B inhibitor zeta Proteins 0.000 description 1
- 101001023705 Homo sapiens Nectin-4 Proteins 0.000 description 1
- 101000633516 Homo sapiens Nuclear receptor subfamily 2 group F member 6 Proteins 0.000 description 1
- 101001137535 Homo sapiens Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 Proteins 0.000 description 1
- 101001091425 Homo sapiens Papilin Proteins 0.000 description 1
- 101000735594 Homo sapiens Peptidyl-prolyl cis-trans isomerase A-like 4G Proteins 0.000 description 1
- 101001072903 Homo sapiens Phosphoglucomutase-2 Proteins 0.000 description 1
- 101000945272 Homo sapiens Phosphorylase b kinase regulatory subunit alpha, liver isoform Proteins 0.000 description 1
- 101000633511 Homo sapiens Photoreceptor-specific nuclear receptor Proteins 0.000 description 1
- 101000611892 Homo sapiens Platelet-derived growth factor D Proteins 0.000 description 1
- 101000974715 Homo sapiens Potassium voltage-gated channel subfamily E member 3 Proteins 0.000 description 1
- 101000617720 Homo sapiens Pregnancy-specific beta-1-glycoprotein 5 Proteins 0.000 description 1
- 101000617721 Homo sapiens Pregnancy-specific beta-1-glycoprotein 6 Proteins 0.000 description 1
- 101000610548 Homo sapiens Proline-rich protein 4 Proteins 0.000 description 1
- 101000959489 Homo sapiens Protein AF-9 Proteins 0.000 description 1
- 101000903886 Homo sapiens Protein BEX2 Proteins 0.000 description 1
- 101000969825 Homo sapiens Protein MROH8 Proteins 0.000 description 1
- 101000610095 Homo sapiens Protein PBDC1 Proteins 0.000 description 1
- 101000920935 Homo sapiens Protein eva-1 homolog B Proteins 0.000 description 1
- 101000822459 Homo sapiens Protein transport protein Sec31A Proteins 0.000 description 1
- 101000613332 Homo sapiens Protocadherin gamma-A1 Proteins 0.000 description 1
- 101000803338 Homo sapiens Putative WASP homolog-associated protein with actin, membranes and microtubules-like protein 1 Proteins 0.000 description 1
- 101000982228 Homo sapiens Putative olfactory receptor 9A1 Proteins 0.000 description 1
- 101000759812 Homo sapiens Putative uncharacterized protein TSPEAR-AS2 Proteins 0.000 description 1
- 101001106812 Homo sapiens Rab11 family-interacting protein 4 Proteins 0.000 description 1
- 101000620856 Homo sapiens Rab5 GDP/GTP exchange factor Proteins 0.000 description 1
- 101000848724 Homo sapiens Rap guanine nucleotide exchange factor 3 Proteins 0.000 description 1
- 101001061896 Homo sapiens Ras GTPase-activating protein 4 Proteins 0.000 description 1
- 101001110313 Homo sapiens Ras-related C3 botulinum toxin substrate 2 Proteins 0.000 description 1
- 101000584765 Homo sapiens Ras-related protein Rab-6B Proteins 0.000 description 1
- 101000580034 Homo sapiens Ras-specific guanine nucleotide-releasing factor RalGPS1 Proteins 0.000 description 1
- 101000665846 Homo sapiens Receptor expression-enhancing protein 3 Proteins 0.000 description 1
- 101000738765 Homo sapiens Receptor-type tyrosine-protein phosphatase N2 Proteins 0.000 description 1
- 101000886098 Homo sapiens Rho guanine nucleotide exchange factor 40 Proteins 0.000 description 1
- 101001125551 Homo sapiens Ribose-phosphate pyrophosphokinase 1 Proteins 0.000 description 1
- 101000652153 Homo sapiens Ribosome biogenesis protein SLX9 homolog Proteins 0.000 description 1
- 101000616512 Homo sapiens SH2 domain-containing protein 3C Proteins 0.000 description 1
- 101000706557 Homo sapiens SUN domain-containing protein 1 Proteins 0.000 description 1
- 101000936917 Homo sapiens Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 Proteins 0.000 description 1
- 101000987310 Homo sapiens Serine/threonine-protein kinase PAK 2 Proteins 0.000 description 1
- 101000621057 Homo sapiens Serum paraoxonase/lactonase 3 Proteins 0.000 description 1
- 101000806155 Homo sapiens Short-chain dehydrogenase/reductase 3 Proteins 0.000 description 1
- 101000585019 Homo sapiens Striatin-3 Proteins 0.000 description 1
- 101000697810 Homo sapiens Syntaxin-5 Proteins 0.000 description 1
- 101000820477 Homo sapiens Syntaxin-binding protein 3 Proteins 0.000 description 1
- 101000665387 Homo sapiens TANK-binding kinase 1-binding protein 1 Proteins 0.000 description 1
- 101000596543 Homo sapiens THAP domain-containing protein 11 Proteins 0.000 description 1
- 101000889527 Homo sapiens TOG array regulator of axonemal microtubules protein 1 Proteins 0.000 description 1
- 101000662809 Homo sapiens Trafficking protein particle complex subunit 4 Proteins 0.000 description 1
- 101000714243 Homo sapiens Transcription factor IIIB 90 kDa subunit Proteins 0.000 description 1
- 101000625533 Homo sapiens Transmembrane anterior posterior transformation protein 1 homolog Proteins 0.000 description 1
- 101000598051 Homo sapiens Transmembrane protein 119 Proteins 0.000 description 1
- 101000763462 Homo sapiens Transmembrane protein 135 Proteins 0.000 description 1
- 101000763493 Homo sapiens Transmembrane protein 248 Proteins 0.000 description 1
- 101000597830 Homo sapiens Transmembrane protein 87A Proteins 0.000 description 1
- 101000611192 Homo sapiens Trinucleotide repeat-containing gene 6B protein Proteins 0.000 description 1
- 101000652492 Homo sapiens Tubulin-specific chaperone cofactor E-like protein Proteins 0.000 description 1
- 101000750283 Homo sapiens Tubulinyl-Tyr carboxypeptidase 2 Proteins 0.000 description 1
- 101000659267 Homo sapiens Tumor suppressor candidate 2 Proteins 0.000 description 1
- 101000772904 Homo sapiens Ubiquitin-conjugating enzyme E2 D1 Proteins 0.000 description 1
- 101000641419 Homo sapiens V-type proton ATPase 16 kDa proteolipid subunit c Proteins 0.000 description 1
- 101000867817 Homo sapiens Voltage-dependent L-type calcium channel subunit alpha-1D Proteins 0.000 description 1
- 101000743543 Homo sapiens Vomeronasal type-1 receptor 3 Proteins 0.000 description 1
- 101000788744 Homo sapiens Zinc finger MYM-type protein 5 Proteins 0.000 description 1
- 101000802315 Homo sapiens Zinc finger protein 551 Proteins 0.000 description 1
- 101000976455 Homo sapiens Zinc finger protein 800 Proteins 0.000 description 1
- 101001032478 Homo sapiens cAMP-dependent protein kinase inhibitor alpha Proteins 0.000 description 1
- 101000802094 Homo sapiens mRNA decay activator protein ZFP36L1 Proteins 0.000 description 1
- 208000021330 IgG4-related disease Diseases 0.000 description 1
- 208000037142 IgG4-related systemic disease Diseases 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 208000004187 Immunoglobulin G4-Related Disease Diseases 0.000 description 1
- 102100029617 Immunoglobulin lambda-like polypeptide 5 Human genes 0.000 description 1
- 102100024039 Inositol 1,4,5-trisphosphate receptor type 1 Human genes 0.000 description 1
- 102100026819 Inositol polyphosphate 1-phosphatase Human genes 0.000 description 1
- 102000013691 Interleukin-17 Human genes 0.000 description 1
- 108050003558 Interleukin-17 Proteins 0.000 description 1
- 101150023517 LCC gene Proteins 0.000 description 1
- 102100032642 Late secretory pathway protein AVL9 homolog Human genes 0.000 description 1
- 102100025948 Leucine-rich repeat-containing protein 27 Human genes 0.000 description 1
- 102100021917 Low-density lipoprotein receptor-related protein 3 Human genes 0.000 description 1
- 102100034709 Lymphocyte cytosolic protein 2 Human genes 0.000 description 1
- 102100033765 Lysine-specific demethylase 9 Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102100031826 Marginal zone B- and B1-cell-specific protein Human genes 0.000 description 1
- 102100030775 Matrix-remodeling-associated protein 7 Human genes 0.000 description 1
- 102100023137 Metal cation symporter ZIP8 Human genes 0.000 description 1
- 101100310648 Mus musculus Sox17 gene Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102100024960 Myotubularin-related protein 13 Human genes 0.000 description 1
- 102100031958 N-alpha-acetyltransferase 40 Human genes 0.000 description 1
- 102100026009 NF-kappa-B inhibitor zeta Human genes 0.000 description 1
- 101100061127 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cox-15 gene Proteins 0.000 description 1
- 102100029528 Nuclear receptor subfamily 2 group F member 6 Human genes 0.000 description 1
- 102100021007 Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 Human genes 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 102100034934 Papilin Human genes 0.000 description 1
- 102100035580 Peptidyl-prolyl cis-trans isomerase A-like 4G Human genes 0.000 description 1
- 102100036629 Phosphoglucomutase-2 Human genes 0.000 description 1
- 102100033548 Phosphorylase b kinase regulatory subunit alpha, liver isoform Human genes 0.000 description 1
- 102100029533 Photoreceptor-specific nuclear receptor Human genes 0.000 description 1
- 102100040682 Platelet-derived growth factor D Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 102100022753 Potassium voltage-gated channel subfamily E member 3 Human genes 0.000 description 1
- 102100022025 Pregnancy-specific beta-1-glycoprotein 5 Human genes 0.000 description 1
- 102100022026 Pregnancy-specific beta-1-glycoprotein 6 Human genes 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 102100040122 Proline-rich protein 4 Human genes 0.000 description 1
- 102100039686 Protein AF-9 Human genes 0.000 description 1
- 102100022953 Protein BEX2 Human genes 0.000 description 1
- 102100021180 Protein GOLM2 Human genes 0.000 description 1
- 101710197448 Protein GOLM2 Proteins 0.000 description 1
- 102100021342 Protein MROH8 Human genes 0.000 description 1
- 102100040170 Protein PBDC1 Human genes 0.000 description 1
- 102100031796 Protein eva-1 homolog B Human genes 0.000 description 1
- 101800000618 Protein kinase C delta type catalytic subunit Proteins 0.000 description 1
- 102100021004 Protein sidekick-1 Human genes 0.000 description 1
- 102100022484 Protein transport protein Sec31A Human genes 0.000 description 1
- 102100040876 Protocadherin gamma-A1 Human genes 0.000 description 1
- 102100030624 Proton myo-inositol cotransporter Human genes 0.000 description 1
- 102100036018 Putative WASP homolog-associated protein with actin, membranes and microtubules-like protein 1 Human genes 0.000 description 1
- 102100026706 Putative olfactory receptor 9A1 Human genes 0.000 description 1
- 102100024999 Putative uncharacterized protein TSPEAR-AS2 Human genes 0.000 description 1
- 102100021313 Rab11 family-interacting protein 4 Human genes 0.000 description 1
- 102100022851 Rab5 GDP/GTP exchange factor Human genes 0.000 description 1
- 102100034584 Rap guanine nucleotide exchange factor 3 Human genes 0.000 description 1
- 102100029555 Ras GTPase-activating protein 4 Human genes 0.000 description 1
- 102100025208 Ras-associated and pleckstrin homology domains-containing protein 1 Human genes 0.000 description 1
- 101710084189 Ras-associated and pleckstrin homology domains-containing protein 1 Proteins 0.000 description 1
- 102100022129 Ras-related C3 botulinum toxin substrate 2 Human genes 0.000 description 1
- 102100030014 Ras-related protein Rab-6B Human genes 0.000 description 1
- 102100027536 Ras-specific guanine nucleotide-releasing factor RalGPS1 Human genes 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102100038273 Receptor expression-enhancing protein 3 Human genes 0.000 description 1
- 102100037404 Receptor-type tyrosine-protein phosphatase N2 Human genes 0.000 description 1
- 102100039653 Rho guanine nucleotide exchange factor 40 Human genes 0.000 description 1
- 102100029508 Ribose-phosphate pyrophosphokinase 1 Human genes 0.000 description 1
- 102100030570 Ribosome biogenesis protein SLX9 homolog Human genes 0.000 description 1
- 102100021798 SH2 domain-containing protein 3C Human genes 0.000 description 1
- 108091006309 SLC2A13 Proteins 0.000 description 1
- 108091006570 SLC33A1 Proteins 0.000 description 1
- 108091006939 SLC39A8 Proteins 0.000 description 1
- 102100031130 SUN domain-containing protein 1 Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 102100027733 Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 Human genes 0.000 description 1
- 102100027939 Serine/threonine-protein kinase PAK 2 Human genes 0.000 description 1
- 102100022833 Serum paraoxonase/lactonase 3 Human genes 0.000 description 1
- 102100037857 Short-chain dehydrogenase/reductase 3 Human genes 0.000 description 1
- 208000021386 Sjogren Syndrome Diseases 0.000 description 1
- 201000002661 Spondylitis Diseases 0.000 description 1
- 101000677856 Stenotrophomonas maltophilia (strain K279a) Actin-binding protein Smlt3054 Proteins 0.000 description 1
- 102100029955 Striatin-3 Human genes 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 102100027973 Syntaxin-5 Human genes 0.000 description 1
- 102100021679 Syntaxin-binding protein 3 Human genes 0.000 description 1
- 201000009594 Systemic Scleroderma Diseases 0.000 description 1
- 206010042953 Systemic sclerosis Diseases 0.000 description 1
- 102100038724 TANK-binding kinase 1-binding protein 1 Human genes 0.000 description 1
- 102100035063 THAP domain-containing protein 11 Human genes 0.000 description 1
- 102100039142 TOG array regulator of axonemal microtubules protein 1 Human genes 0.000 description 1
- 239000004012 Tofacitinib Substances 0.000 description 1
- 102100037496 Trafficking protein particle complex subunit 4 Human genes 0.000 description 1
- 102100036535 Transcription factor IIIB 90 kDa subunit Human genes 0.000 description 1
- 102100024677 Transmembrane anterior posterior transformation protein 1 homolog Human genes 0.000 description 1
- 102100037029 Transmembrane protein 119 Human genes 0.000 description 1
- 102100027031 Transmembrane protein 135 Human genes 0.000 description 1
- 102100027014 Transmembrane protein 248 Human genes 0.000 description 1
- 102100035303 Transmembrane protein 87A Human genes 0.000 description 1
- 102100040244 Trinucleotide repeat-containing gene 6B protein Human genes 0.000 description 1
- 102100030286 Tubulin-specific chaperone cofactor E-like protein Human genes 0.000 description 1
- 102100021162 Tubulinyl-Tyr carboxypeptidase 2 Human genes 0.000 description 1
- 102100036129 Tumor suppressor candidate 2 Human genes 0.000 description 1
- 102100029153 UDP-glucuronosyltransferase 1A3 Human genes 0.000 description 1
- 101710205493 UDP-glucuronosyltransferase 1A3 Proteins 0.000 description 1
- 102100040213 UDP-glucuronosyltransferase 1A7 Human genes 0.000 description 1
- 101710205340 UDP-glucuronosyltransferase 1A7 Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102100030433 Ubiquitin-conjugating enzyme E2 D1 Human genes 0.000 description 1
- 102100034171 V-type proton ATPase 16 kDa proteolipid subunit c Human genes 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 102100038345 Vomeronasal type-1 receptor 3 Human genes 0.000 description 1
- 108091009222 YME1L1 Proteins 0.000 description 1
- 102100025415 Zinc finger MYM-type protein 5 Human genes 0.000 description 1
- 102100034649 Zinc finger protein 551 Human genes 0.000 description 1
- 102100023643 Zinc finger protein 800 Human genes 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 229940119059 actemra Drugs 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 108010029483 alpha 1 Chain Collagen Type I Proteins 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000012197 amplification kit Methods 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 229940059756 arava Drugs 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000001815 biotherapy Methods 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 102100038086 cAMP-dependent protein kinase inhibitor alpha Human genes 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 229940090100 cimzia Drugs 0.000 description 1
- 230000008045 co-localization Effects 0.000 description 1
- 238000013264 cohort analysis Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 238000004883 computer application Methods 0.000 description 1
- 208000018631 connective tissue disease Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 108010026647 cytochrome P-450 4X1 Proteins 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000009274 differential gene expression Effects 0.000 description 1
- 238000000375 direct analysis in real time Methods 0.000 description 1
- 238000005315 distribution function Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000012063 dual-affinity re-targeting Methods 0.000 description 1
- 108010011867 ecallantide Proteins 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 229940104788 entyvio Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000003500 gene array Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 229940037993 inflectra Drugs 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- VBGWSQKGUZHFPS-VGMMZINCSA-N kalbitor Chemical compound C([C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]2C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=3C=CC=CC=3)C(=O)N[C@H](C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)NCC(=O)NCC(=O)N[C@H]3CSSC[C@H](NC(=O)[C@@H]4CCCN4C(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CO)NC(=O)[C@H](CC=4NC=NC=4)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O)CSSC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC3=O)CSSC2)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=2NC=NC=2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N1)[C@@H](C)CC)[C@H](C)O)=O)[C@@H](C)CC)C1=CC=CC=C1 VBGWSQKGUZHFPS-VGMMZINCSA-N 0.000 description 1
- 229940018902 kalbitor Drugs 0.000 description 1
- 229940054136 kineret Drugs 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 238000009115 maintenance therapy Methods 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 108091091482 miR-4680 stem-loop Proteins 0.000 description 1
- 108091071572 miR-9-2 stem-loop Proteins 0.000 description 1
- 238000010295 mobile communication Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 238000013188 needle biopsy Methods 0.000 description 1
- 238000003012 network analysis Methods 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229940035567 orencia Drugs 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000006320 pegylation Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 231100000205 reproductive and developmental toxicity Toxicity 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 108091006024 signal transducing proteins Proteins 0.000 description 1
- 102000034285 signal transducing proteins Human genes 0.000 description 1
- 230000007727 signaling mechanism Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000010741 sumoylation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000034512 ubiquitination Effects 0.000 description 1
- 238000010798 ubiquitination Methods 0.000 description 1
- 230000009452 underexpressoin Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229940039916 xeljanz Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Data Mining & Analysis (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Chemical & Material Sciences (AREA)
- Evolutionary Biology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Databases & Information Systems (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Primary Health Care (AREA)
- Bioethics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Artificial Intelligence (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Software Systems (AREA)
- Evolutionary Computation (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Physiology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063073336P | 2020-09-01 | 2020-09-01 | |
| PCT/US2021/048346 WO2022051245A2 (en) | 2020-09-01 | 2021-08-31 | Methods and systems for predicting response to anti-tnf therapies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL300978A true IL300978A (en) | 2023-04-01 |
Family
ID=80492102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL300978A IL300978A (en) | 2020-09-01 | 2021-08-31 | Methods and systems for predicting response to anti-TNF treatments |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230282367A1 (https=) |
| EP (1) | EP4208256A4 (https=) |
| JP (1) | JP2023538963A (https=) |
| KR (1) | KR20240018404A (https=) |
| CN (1) | CN117615780A (https=) |
| AU (1) | AU2021336781A1 (https=) |
| CA (1) | CA3191195A1 (https=) |
| GB (1) | GB2616129A (https=) |
| IL (1) | IL300978A (https=) |
| MX (1) | MX2023002446A (https=) |
| WO (1) | WO2022051245A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019178546A1 (en) | 2018-03-16 | 2019-09-19 | Scipher Medicine Corporation | Methods and systems for predicting response to anti-tnf therapies |
| GB2603294A (en) | 2019-06-27 | 2022-08-03 | Scipher Medicine Corp | Developing classifiers for stratifying patients |
| WO2023150731A2 (en) * | 2022-02-04 | 2023-08-10 | Scipher Medicine Corporation | Systems and methods for predicting response to anti-tnf therapies |
| CN120015309B (zh) * | 2025-01-14 | 2025-12-12 | 中国人民解放军军事科学院军事医学研究院 | 用于急性高原反应（ams）易感性分群的装置 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2679996A1 (en) * | 2007-05-31 | 2014-01-01 | AbbVie Inc. | Biomarkers predictive of the responsiveness to TNF-alfa inhibitors in autoimmune disorders |
| JP5719591B2 (ja) * | 2007-06-08 | 2015-05-20 | バイオジェン アイデック エムエー インコーポレイティドＢｉｏｇｅｎ Ｉｄｅｃ Ｉｎｃ． | 抗ｔｎｆ応答性または非応答性を予測するためのバイオマーカー |
| CN102171365B (zh) * | 2008-08-25 | 2014-01-29 | 森托科尔奥索生物科技公司 | 用于溃疡性结肠炎和相关疾病的抗tnf治疗的生物标记物 |
| KR20220065091A (ko) * | 2014-03-27 | 2022-05-19 | 제넨테크, 인크. | 염증성 장 질환의 진단 및 치료 방법 |
| EP3654993A4 (en) * | 2017-07-17 | 2021-08-25 | The Broad Institute, Inc. | CELL ATLAS OF HEALTHY HUMAN COLUMN AND HUMAN COLUMN WITH COLITIS ULCEROSA |
| WO2019178546A1 (en) * | 2018-03-16 | 2019-09-19 | Scipher Medicine Corporation | Methods and systems for predicting response to anti-tnf therapies |
| EA202191354A1 (ru) * | 2018-11-15 | 2021-08-11 | Янссен Байотек, Инк. | Способы и композиции для прогнозирования ответа на терапию воспалительного заболевания кишечника |
| GB2603294A (en) * | 2019-06-27 | 2022-08-03 | Scipher Medicine Corp | Developing classifiers for stratifying patients |
-
2021
- 2021-08-31 IL IL300978A patent/IL300978A/en unknown
- 2021-08-31 MX MX2023002446A patent/MX2023002446A/es unknown
- 2021-08-31 CA CA3191195A patent/CA3191195A1/en active Pending
- 2021-08-31 GB GB2303624.7A patent/GB2616129A/en active Pending
- 2021-08-31 CN CN202180074291.7A patent/CN117615780A/zh active Pending
- 2021-08-31 AU AU2021336781A patent/AU2021336781A1/en not_active Abandoned
- 2021-08-31 WO PCT/US2021/048346 patent/WO2022051245A2/en not_active Ceased
- 2021-08-31 KR KR1020237011014A patent/KR20240018404A/ko active Pending
- 2021-08-31 JP JP2023513939A patent/JP2023538963A/ja active Pending
- 2021-08-31 EP EP21864967.1A patent/EP4208256A4/en not_active Withdrawn
-
2023
- 2023-02-28 US US18/176,288 patent/US20230282367A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3191195A1 (en) | 2022-03-10 |
| WO2022051245A2 (en) | 2022-03-10 |
| KR20240018404A (ko) | 2024-02-13 |
| CN117615780A (zh) | 2024-02-27 |
| AU2021336781A1 (en) | 2023-05-11 |
| MX2023002446A (es) | 2023-05-12 |
| GB202303624D0 (en) | 2023-04-26 |
| EP4208256A4 (en) | 2024-09-25 |
| AU2021336781A9 (en) | 2025-03-13 |
| WO2022051245A3 (en) | 2022-04-14 |
| US20230282367A1 (en) | 2023-09-07 |
| GB2616129A (en) | 2023-08-30 |
| EP4208256A2 (en) | 2023-07-12 |
| JP2023538963A (ja) | 2023-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12525318B2 (en) | Method of monitoring anti-TNF therapy in a subject suffering from rheumatoid arthritis based in part on a trained machine learning classifier | |
| US11987620B2 (en) | Methods of treating a subject with an alternative to anti-TNF therapy | |
| US20230282367A1 (en) | Methods and systems for predicting response to anti-tnf therapies | |
| US20260057960A1 (en) | Systems and methods for predicting response to anti-tnf therapies | |
| US20250270307A1 (en) | Methods of classifying and treating patients | |
| WO2022271724A1 (en) | Methods and systems for therapy monitoring and trial design | |
| WO2022271717A1 (en) | Methods and systems for personalized therapies | |
| CN117813402A (zh) | 分类和治疗患者的方法 | |
| CA3212448A1 (en) | Methods of classifying and treating patients |